头颈癌放疗或放化疗期间血压变化模式
本研究纳入451例连续接受放疗或放化疗的头颈癌患者,收集并分析其血压变化数据。结果显示,接受3DCRT的患者血压下降幅度大于IMRT-IGRT患者;女性舒张压下降幅度大于男性(p=0.03);治疗结束时收缩压下降(较基线降低10%)与体重下降超过基线10%显著相关(p=0.03)。
要点
- 3DCRT患者血压下降幅度大于IMRT-IGRT患者。
- 女性患者舒张压下降幅度大于男性患者(p=0.03)。
- 收缩压下降(较基线降低10%)与体重下降超过基线10%显著相关(p=0.03)。
核心结论
- 头颈癌患者放疗或放化疗期间血压下降受治疗技术和性别显著影响,并与显著体重下降强相关。
研究设计与样本
- 研究纳入451例连续接受放疗或放化疗的头颈癌患者,收集、汇编并分析其数据。
主要发现
- 451例患者中,男性376例(82%),女性75例(18%),中位年龄52岁。
- 接受3DCRT的患者血压下降幅度大于接受IMRT-IGRT的患者,包括收缩压和平均动脉压。
- 女性患者舒张压下降幅度大于男性患者(p=0.03)。
- 治疗结束时,收缩压下降(较基线降低10%)与体重下降超过基线10%显著相关(p=0.03)。
临床怎么用
- 头颈癌患者放疗或放化疗期间应监测血压,尤其对接受3DCRT、女性及体重显著下降者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate patterns of blood pressure (BP) changes in patients with head and neck cancer (HNC) receiving radiation (RT)/chemo-radiation (CRT) METHODS: This study included data collection, compilation, and analysis of 451 consecutive HNC patients who underwent RT/CRT. RESULTS: Out of 451 patients, 376 (82%) were male and 75 (18%) were female with a median age of 52 years. Patients receiving 3DCRT experienced greater fall in BP, including for SBP and MAP, compared to those receiving IMRT-IGRT. Female patients experienced greater fall in diastolic BP as compared to male patients (p: 0.03). At the end of treatment, we observed a significant association between a fall in systolic BP (decrease by 10% of baseline) and weight loss of more than 10% of baseline weight (p: 0.03). CONCLUSION: Fall in BP during RT/CRT is significantly affected by treatment technique and sex and is strongly associated with significant weight loss.
引用
- Pandit PN, Patil RA, Palwe VS, et al. Patterns of blood pressure changes in patients with head and neck cancer receiving radiotherapy or chemo-radiotherapy at a tertiary cancer centre. Head Neck. 2020. PMID: 33372394. doi:10.1002/hed.26590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。